MeAgain: GLP-1 all-in-one app
79
MeAgain: GLP-1 all-in-one app
MeAgain: GLP-1 all-in-one app is an iOS app from Dots Future Technologies in the Health & Fitness category, currently rated 4.8★ across 16,563 ratings. Initial signal reads as largely positive sentiment, users highlighting consistency and feature depth.
Quality Score is 79: Strong (healthy traction). For a Health & Fitness app, that means healthy traction. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
📊 Performance Tracking LIVE
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| 📦 Asset bundle (110 MB) | +$24K |
| ⚙ Health & Fitness complexity ×1.40 | +$29K |
Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
| 📺 Ad-supported base | 15× MRR |
| ⭐ ★ rating ≥ 4.7 (premium) | +15% |
| 🏷 Health & Fitness category multiple | +10% |
Synthetic estimate from ratings × category benchmarks. Calibrated against 2024-2026 mobile-attribution retention + DAU/MAU reports. Numbers are US-storefront-equivalent — true global audience can be 5-10× larger for international apps. Full math + source list on /methodology.
| 📲 Health & Fitness engagement | ~70 installs / rating |
| 🔁 Health & Fitness D30 retention | 22% |
| 📍 DAU / MAU stickiness | 0.35 |
How we forecast this revenue
MEDIUM CONFIDENCEBU Investment Matrix
Building · 56/100MID TIERSUBSCRIPTIONcompetitive build-out- 💰 Revenue: Modest — $3K - $7K/mo · MID tier · medium confidence, trajectory unclear.
- ⭐ Quality: 4.8★ across 16,563 reviews — strong (top 10%).
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Moderate — scam/fraud mentions detected, rating drift -0.40 ★ (recent 50 vs lifetime).
💰 Forecast Revenue / mo
MODEL| Mid install base (16,563 ratings)METRIC | +$5,500 | |
| subscriptionREVIEW | +$2,500 | |
| Excellent rating (4.8★)METRIC | +$2,200 | |
| worth every pennyREVIEW | +$2,000 | |
| bugsREVIEW | −$1,800 | |
| 5 starREVIEW | +$1,800 | |
| cancelledREVIEW | −$1,500 | |
| excellent appREVIEW | +$1,500 | |
| highly recommendREVIEW | +$1,400 | |
| slowREVIEW | −$1,200 | |
| support teamREVIEW | +$900 | |
| priceyREVIEW | −$800 | |
| Ad-supported / freemiumMETRIC | +$600 | |
| Single-language (English only)METRIC | −$400 | |
| Growing app (1y old)METRIC | +$200 |
📈 Reviews Growth
LIVE⭐ Rating Trend
LIVE🆕 What's New · v2.2.5
This update includes fixes and improvements for daily tracking across shots, pills, food logging, side-effect notes, protein, fiber, water, weight and progress.
MeAgain is for tracking and education only and does not provide medical advice.
Profile & Insights
Identification
- App name
- MeAgain: GLP-1 all-in-one app
- Developer
- Dots Future Technologies
- Bundle ID
- app.meagain.app
- App Store URL
- Open in App Store
- Category
- Health & Fitness
- Content rating
- 12+
- Languages
- EN
Company
- Website
- Not found
- Tagline
- Your Trusted GLP-1 Partner
- Description
- Track shots or pills, food, protein, fiber, water, side effects, weight, progress photos, and medication context in one GLP-1 app built for daily follow-through.
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Available
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $27.6K/mo
- Top-grossing rank
- 🇺🇸#34 /100
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Funding
Press & Links
Contacts & Socials
- Socials
- facebook facebook.com/profile.php?id=615745283… · instagram instagram.com/me_again_glp1 · tiktok tiktok.com/@meagain_the_glp1_company · youtube youtube.com/@MeAgain_GLP-1
- support@meagain.com
- Phone
- Not found
- Contact page
- meagain.com/support
- About page
- Not found
📈Ratings growth18,198 ratings+1257% lifetimeShow 3-year history estimate ▾
in US, GB, DE, FR, JP, CA, AU, BR, IN
📝 About this app
Use MeAgain for Zepbound®, Wegovy® injection or pill, Ozempic®, Mounjaro®, Foundayo®, semaglutide, tirzepatide, oral GLP-1s and weekly injection routines.
GLP-1 tracking should not feel like another job. There is shot day, pill timing, food noise, low appetite, protein and water goals, side effects, weight stalls, progress photos and dose-day patterns. MeAgain brings the routine together with less mental load, less guesswork and one place to stay on top of what matters.… View full description on the official store →
What Worked™ · Development Pipeline
10 EVENTS TRACKEDVoice of Customer
Based on 527 reviews across 6 marketsMulti-Country Performance
Available in 9 of 9 monitored markets| Market | Rating | Reviews | Current version |
|---|---|---|---|
| 🇦🇺 AU | 4.52381★ | 126 | 4.52381★ this version |
| 🇧🇷 BR | 4.4375★ | 16 | 4.4375★ this version |
| 🇨🇦 CA | 4.70472★ | 254 | 4.70472★ this version |
| 🇩🇪 DE | 4.6087★ | 23 | 4.6087★ this version |
| 🇫🇷 FR | 5★ | 19 | 5★ this version |
| 🇬🇧 GB | 4.7111★ | 135 | 4.7111★ this version |
| 🇮🇳 IN | 4.06667★ | 15 | 4.06667★ this version |
| 🇯🇵 JP | 3★ | 4 | 3★ this version |
| 🇺🇸 US | 4.80539★ | 17,892 | 4.80539★ this version |
Track this app’s revenue
FREE📝 Description
95
Why high confidence: 16,563 ratings · no founder-verified revenue (model estimate only).
